Clinical trial
Cardiac Effects of Norepinephrine After the Initial Phase of Septic Shock
NCT05761522 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cardiac Effects of Norepinephrine After the Initial Phase of Septic Shock
- Lead sponsor
- CHU de Reims
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 21, 2023
- Completion date
- December 21, 2025
- Enrollment
- 49 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
septic shock